Nöropatik Ağrı Nedeniyle Antiepileptik (Antikonvülzan) Tedavi Alan Hastalarda B12 ve Folik Asit (Folat) Düzeyinin Tedavi Öncesi ve Sonrası Retrospektif İncelenmesi
PDF
Atıf
Paylaş
Talep
Özgün Araştırma
CİLT: 11 SAYI: 3
P: 279 - 289
Eylül 2026

Nöropatik Ağrı Nedeniyle Antiepileptik (Antikonvülzan) Tedavi Alan Hastalarda B12 ve Folik Asit (Folat) Düzeyinin Tedavi Öncesi ve Sonrası Retrospektif İncelenmesi

Bagcilar Med Bull 2026;11(3):279-289
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 30.09.2025
Kabul Tarihi: 16.09.2026
Online Tarih: 29.09.2026
Yayın Tarihi: 29.09.2026
PDF
Atıf
Paylaş
Talep

Öz

Amaç

Bu çalışmanın amacı, nöropatik ağrı (NP) tedavisinde sıklıkla kullanılan antiepileptik ilaçların (pregabalin ve gabapentin) serum vitamin B12 ve folat düzeyleri üzerindeki etkilerini araştırmaktır.

Yöntem

Bu retrospektif çalışma, 1 Haziran 2024 ile 31 Aralık 2024 tarihleri arasında pregabalin veya gabapentin tedavisi gören ve NP tanısı konmuş 96 yetişkin hastanın elektronik kayıtlarının incelenmesiyle gerçekleştirilmiştir. Etik kurul onayı 8 Ocak 2025 tarihinde alınmış olup, veri erişimi ve istatistiksel analizler bu tarihten sonra başlatılmıştır. Serum B12 vitamini, folat ve hematolojik parametreler, antiepileptik ilaç tedavisi başlamadan önce yapılan rutin laboratuvar testlerinden ve tedavi başlangıcından en az üç ay sonra gerçekleştirilen ilk takip testlerinden elde edildi. İstatistiksel analizlerde, hasta içi eşleştirilmiş karşılaştırmalar için veri dağılımına göre Wilcoxon işaretli sıralar testi veya eşleştirilmiş örneklem t-testi kullanıldı.

Bulgular

Potansiyel olarak uygun görülen 287 hastadan 96’sı uygunluk kriterlerini karşıladı ve nihai analize dahil edildi. Tedavi öncesi değerlerle karşılaştırıldığında, tedavi sonrası B12 vitamini düzeyleri daha düşüktü (416,0 pg/mL’den 282,0 pg/mL’ye, p=0,001) ve folat düzeylerinde de azalma gözlendi (8,15 ng/mL’den 7,45 ng/mL’ye, p=0,003). Alt grup analizlerinde, pregabalin alan hastalarda hem B12 vitamini (448,0 pg/mL’den 292,5 pg/mL’ye, p=0,001) hem de folat (7,9 ng/mL’den 7,5 ng/mL’e, p=0,007) düzeylerinde istatistiksel olarak anlamlı düşüşler görülürken, gabapentin ile tedavi edilenlerde B12 vitamini (368,0 pg/mL’den 273,0 pg/mL’ye, p=0,001) ve D vitamini (23,9 ng/mL’den 15,7 ng/mL’ye, p=0,021) düzeylerinde anlamlı düşüşler gözlendi. Cinsiyete göre tabakalandırılmış analizlerde, hem erkeklerde hem de kadınlarda B12 vitamini ve folat düzeylerinde grup içi anlamlı azalmalar saptandı.

Sonuç

NP tedavisinde yaygın olarak kullanılan pregabalin ve gabapentin, serum vitamin B12 ve folat düzeylerinde anlamlı azalma ile ilişkili bulunmuştur. Bu bulgular, antiepileptik ilaç kullanımı ile vitamin seviyesindeki azalma arasında potansiyel bir ilişki-olduğunu düşündürmektedir. Klinik uygulamada rutin vitamin takibi düşünülebilir; ancak bu gözlemsel bulgular nedensellik ilişkisini kanıtlamamaktadır ve bu bağlantıları doğrulamak için daha fazla prospektif çalışma gereklidir.

Anahtar Kelimeler:
Antiepileptik ilaçlar, folat, gabapentin, nöropatik ağrı, pregabalin, vitamin B12

Kaynaklar

1
Zhang Y, Mustieles V, Wang YX, Sun Y, Agudelo J, Bibi Z, et al. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study. Lancet Planet Health. 2023;7(6):e449-e458.
2
Bouhassira D, Attal N. Translational neuropathic pain research: a clinical perspective. Neuroscience. 2016;338:27-35.
3
Rosner J, Attal N, Finnerup NB. Clinical pharmacology of neuropathic pain. Int Rev Neurobiol. 2024;179:403-430.
4
Ma YC, Kang ZB, Shi YQ, Ji WY, Zhou WM, Nan W. The complexity of neuropathic pain and central sensitization: exploring mechanisms and therapeutic prospects. J Integr Neurosci. 2024;23(5):89.
5
Soliman N, Kersebaum D, Lawn T, Sachau J, Sendel M, Vollert J. Improving neuropathic pain treatment - by rigorous stratification from bench to bedside. J Neurochem. 2024;168(11):3699-3714.
6
Rahman MM, Jo YY, Kim YH, Park CK. Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management. Life Sci. 2024;355:122954.
7
Testa L, Dotta S, Vercelli A, Marvaldi L. Communicating pain: emerging axonal signaling in peripheral neuropathic pain. Front Neuroanat. 2024;18:1398400.
8
Shkodina AD, Bardhan M, Chopra H, Anyagwa OE, Pinchuk VA, Hryn KV, et al. Pharmacological and non-pharmacological approaches for the management of neuropathic pain in multiple sclerosis. CNS Drugs. 2024;38(3):205-224.
9
Boccella S, De Filippis L, Giorgio C, Brandolini L, Jones M, Novelli R, et al. Combination drug therapy for the management of chronic neuropathic pain. Biomolecules. 2023;13(12):1802.
10
Andrejic N, Bozovic I, Moradi H, Tataei R, Knezevic NN. Neuropathic pain management: a focused review of current treatments and novel data from main ongoing clinical trials. Expert Opin Investig Drugs. 2025;34(4):287-299.
11
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, et al. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technol Assess. 2022;26(39):1-100.
12
Liu X, Wei L, Zeng Q, Lin K, Zhang J. The treatment of topical drugs for postherpetic neuralgia: a network meta-analysis. Pain Physician. 2020;23(6):541-551.
13
Moisset X, Bouhassira D, Attal N. French guidelines for neuropathic pain: an update and commentary. Rev Neurol (Paris). 2021;177(7):834-837.
14
Dwajani S, Ravi L, Bindu CM, Prema R. Effect of antiepileptic drugs on serum vitamin B12 and folic acid among children with epilepsy in Bangalore. Biomedical and Pharmacology Journal. 2024;17(1):263-269.
15
Moisset X. Neuropathic pain: evidence based recommendations. Presse Med. 2024;53(2):104232.
16
Freynhagen R, Baron R, Huygen F, Perrot S. Narrative review of the efficacy and safety of the high-concentration (179mg) capsaicin patch in peripheral neuropathic pain with recommendations for clinical practice and future research. Pain Rep. 2025;10(2):e1235.
17
Kathiravan M, Kavitha S, Shanthi R. To determine the effect of long-term antiepileptic drug on the serum folate and vitamin B12 among epileptic patients. Sci Rep. 2021;11(1):4393.
18
Petroianu GA, Aloum L, Adem A. Neuropathic pain: mechanisms and therapeutic strategies. Front Cell Dev Biol. 2023;11:1072629.
19
Safahani M, Aligholi H, Asadi-Pooya AA. Management of antiepileptic drug-induced nutrition-related adverse effects. Neurol Sci. 2020;41(12):3491-3502.
20
Huang HL, Zhou H, Wang N, Yu CY. Effects of antiepileptic drugs on the serum folate and vitamin B12 in various epileptic patients. Biomed Rep. 2016;5(4):413-416.
21
Xu Y, Zhang N, Xu S, Xu H, Chen S, Xia Z. Effects of phenytoin on serum levels of homocysteine, vitamin B12, folate in patients with epilepsy: a systematic review and meta-analysis (PRISMA-compliant article). Medicine (Baltimore). 2019;98(12):e14844.
22
Becit-Kizilkaya M, Oncu S, Bugra Koca H, Cavusoglu D. Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: a cross-sectional study. Epilepsy Behav. 2024;155:109802.
23
O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010;2(3):299-316.
24
Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:5226-5231.
25
Jones KS, Collins D, Meadows SR, Koulman A, Page P. National Diet and Nutrition Survey data reveal a decline in folate status in the United Kingdom population between 2008 and 2019. Am J Clin Nutr. 2023;118(6):1182-1191.
26
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. Erratum in: J Clin Endocrinol Metab. 2011;96(12):3908. Erratum in: J Clin Endocrinol Metab. 2024;109(10):e1991.
27
Seğmen F, Aydemir S, Küçük O, Dokuyucu R. The roles of vitamin D levels, gla-rich protein (GRP) and matrix gla protein (MGP), and inflammatory markers in predicting mortality in intensive care patients: a new biomarker link? Metabolites. 2024;14(11):620.
28
Julian T, Syeed R, Glascow N, Angelopoulou E, Zis P. B12 as a treatment for peripheral neuropathic pain: a systematic review. Nutrients. 2020;12(8):2221.
29
Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol. 2011;69(2):352-359.
30
Reyes Fernandez PC, Wright CS, Warden SJ, Hum J, Farach-Carson MC, Thompson WR. Effects of gabapentin and pregabalin on calcium homeostasis: implications for physical rehabilitation of musculoskeletal tissues. Curr Osteoporos Rep. 2022;20(6):365-378.
31
Alles SRA, Cain SM, Snutch TP. Pregabalin as a pain therapeutic: beyond calcium channels. Front Cell Neurosci. 2020;14:83.
32
He Q, Li J. The evolution of folate supplementation - from one size for all to personalized, precision, poly-paths. J Transl Int Med. 2023;11(2):128-137.
33
Li Y, Bromley R, Meador KJ, Bjork MH, Pennell PB, Voinescu PE; Epilepsy in the Childbearing Age through Menopause Consortium (ECAM). Folate supplement dosage for pregnant people with epilepsy: survey of international experts recommendation and current practices. Epileptic Disord. 2025;27(6):1209-1216.
34
Eghrari NB, Yazji IH, Yavari B, Van Acker GM, Kim CH. Risk of dementia following gabapentin prescription in chronic low back pain patients. Reg Anesth Pain Med. 2025:rapm-2025-106577. Epub ahead of print.
35
Mohan A, Kumar R, Kumar V, Yadav M. Homocysteine, vitamin B12 and folate level: possible risk factors in the progression of chronic heart and kidney disorders. Curr Cardiol Rev. 2023;19(4):e090223213539.
36
Sirivarasai J, Shantavasinkul PC, Thitiwiwatkul M, Monsuwan W, Panpunuan P, Sritara P. Association between plasma homocysteine, folate, vitamin B12 levels, and metabolic dysfunction indices in elderly with arterial stiffness. J Clin Med. 2025;14(9):2998.
37
Qu R, Han A, Zhao Y, Qu X, Zhu Y. Characteristics of clinical manifestations and molecular genetics of inherited hyperhomocysteinemia in children and adolescents: a single center experience from China. Front Neurol. 2025;16:1588273.